We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Hathaway Pease Russell

Foley Hoag LLP

Results 1 to 2 of 2
Most popular |Most recent


So now what? Implications of the Supreme Court’s Myriad ruling

USA - June 17 2013 Late last week, the United States Supreme Court issued its long-awaited decision in Association of Molecular Pathology v. Myriad Genetics, Inc. The...

Claire Laporte, Marco J. Quina.


Are genes no longer patentable?

USA - April 2 2010 In a much-anticipated decision that has attracted the attention of pharmaceutical and biotech companies, medical researchers, physicians, attorneys and patients concerned about their risk for breast or ovarian cancer, Judge Robert W. Sweet of the U.S. District Court for the Southern District of New York ruled in favor of the plaintiffs on March 29, 2010 in Association for Molecular Pathology, et al. v. United States Patent and Trademark Office, et al....

Beth E. Arnold, Donald R. Ware.